この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Himjyot J.に依頼
Sweden
An enthusiastic, self-motivated scientist with excellent interpersonal and communication skills and 10+ years experience
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Technical Writing
Research
Feasibility Study,
Systematic Literature Review
Product Development
Formulation
職務経験
Team Lead
Cellink
11月 2019 - 現在 ![]()
Senior Scientist
Novonordisk
12月 2017 - 10月 2019
Independent Postdoc Researcher
AstraZeneca
2月 2015 - 12月 2017
Postdoc Researcher
Karolinska Institute
10月 2011 - 2月 2015
Summer Intern
Pelago Bioscience
5月 2014 - 7月 2014
学歴
Ph.D
University of Freiburg
1月 2006 - 10月 2010
Master of Science-Biotechnology
Indian Institute of Technology- Roorkee
1月 2000 - 8月 2002
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
(2020). Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery . Nature Communications.
(2020). Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles . SLAS discovery : advancing life sciences R & D.
(2018). NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populations . Stem Cell Research.
(2017). ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration . The EMBO journal.
(2015). Bystander communication and cell cycle decisions after DNA damage . Frontiers in Genetics.
(2014). Assessing kinetics from fixed cells reveals activation of the mitotic entry network at the S/G2 transition . Molecular cell.
(2014). Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase . Cell cycle (Georgetown, Tex.).
(2011). The chaperone network connected to human ribosome-associated complex . Molecular and cellular biology.
(2010). BiP modulates the affinity of its co-chaperone ERj1 for ribosomes . The Journal of biological chemistry.